A Partnership of the Crohn’s & Colitis Foundation and
the American Gastroenterological Association
the American Gastroenterological Association
Join the Conversation
Revolutionizing IBD Care
We look forward to seeing you in person at the 2025 Crohn’s & Colitis Congress®, taking place February 6–8, 2025, in San Francisco.
Join your colleagues from around the world and across the entire spectrum of clinical care and science at the premier conference on inflammatory bowel disease (IBD). Don’t miss your opportunity to gain a multidisciplinary perspective on treating IBD. Discover different perspectives, leave with practical information you can immediately implement, and hear about potential treatments on the horizon.
The Crohn’s & Colitis Congress is a partnership of the Crohn’s & Colitis Foundation and the American Gastroenterological Association. Many thanks to our attendees, chairs, faculty, exhibitors, supporting organizations and partners for making the 2024 Congress such a success.
See how to obtain CME and MOC credit from the 2024 Congress.
Please check back for updates.
We are thrilled to announce the Crohn’s & Colitis Congress®, a partnership of the Crohn’s & Colitis Foundation and the American Gastroenterological Association, will take place on January 25-27, 2024, at the Bellagio in Las Vegas.
Join your colleagues from around the world and across the entire spectrum of clinical care and science at the premier conference on inflammatory bowel disease (IBD) as we continue our mission of transforming IBD care.
Don’t miss all the excitement! Gain a multidisciplinary perspective on treating IBD. Discover different perspectives, leave with practical information you can immediately implement, and hear about potential treatments on the horizon.
We look forward to seeing you in person. Please check back for updates.
The Crohn’s & Colitis Foundation and AGA have cancelled in-person programming due to the challenges the coronavirus omicron variant outbreak places on the medical community. In order to have the safest and most educational meeting, all Crohn’s & Colitis Congress programming will be held virtually on January 20-22.
Speakers, moderators and poster presenters will receive more details by email later this week about your virtual participation.
Exhibitors will be contacted directly by a member of Congress management for further details.
Attendees: All registrations will be converted to virtual and housing reservations will be cancelled.
We look forward to a dynamic and educational virtual and on-demand experience. Thank you for your patience with this transition. We share our best wishes for your health and safety.
WE HOPE TO SEE YOU VIRTUALLY ON JANUARY 20–22, 2022.
Abstract Notifications: Monday, December 5, 2022
Advanced Registration Deadline: Wednesday, December 14, 2022
Drs. Peter Higgins and Laura Raffals reveal why they are excited to bring you the 2024 Congress.
You can still register to join the live meeting. If you miss anything, the on-demand programming will be released on February 1, 2021, and be available for 90 days.
The 2024 Crohn’s & Colitis Congress was supported by an educational grant from:
Ferring Pharmaceuticals, Inc.
Lilly
Pfizer
Salix Pharmaceuticals, Inc.
Takeda Pharmaceuticals U.S.A., Inc.
Bristol Myers Squibb
AbbVie Inc.
Salix Pharmaceuticals, a division of Bausch Health US, LLC
Pfizer Inc.
Takeda Pharmaceuticals U.S.A., Inc.
The 2024 Crohn’s & Colitis Congress partnered with:
The 2024 Crohn’s & Colitis Congress partnered with: